 It is hypothesized that a strategy using prophylactic oral Tranexamic Acid TXA with therapeutic platelet transfusions is safe and effective compared to prophylactic platelet transfusions in patients undergoing an autologous hematopoietic stem cell transplantation who are at risk for bleeding. 